BITNEWS

Vivos Therapeutics (NASDAQ: VVOS) Conducts 2024 Annual Meeting, Elects Directors and Ratifies Key Proposals

Vivos Therapeutics, Inc. recently held its 2024 annual meeting of stockholders on November 26, 2024, as reported in an 8-K filing submitted to the Securities and Exchange Commission. At the meeting, a total of 4,765,300 shares of common stock, constituting the voting stock as of the October 4, 2024 record date, were eligible to vote. [...]

ONLY AVAILABLE IN PAID PLANS

Published by: americanbankingnews

Read full article here: https://www.americanbankingnews.com/2024/11/30/vivos-therapeutics-nasdaq-vvos-conducts-2024-annual-meeting-elects-directors-and-ratifies-key-proposals.html